Фиброз печени: литература
Boothe HW, Howe LM, Edwards JF, et al: Multiple extrahepatic portosystemic shunts in dogs: 30 cases (1981-1993). J Am Vet Med Assoc 208:1849,1996. Vena cava bandingin dogs with multiple portosystemic shunts is not superior to medical and nutritional treatment.
Britton RS, Bacon BR: Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology 41:343, 1994. Free radicals may play a role in initiating or perpetuating cellular damage and fibrosis in liver disease.
Leveille CR, Arias IM: Pathophysiology and pharmacologic modulation of hepatic fibrosis. J Vet Intern Med 7:73, 1993. A thorough review of the mechanisms of hepatic fibrosis and antifibrotic drugs.
Leveille-Webster CR, Center SA: Chronic hepatitis: Therapeutic considerations. In: Kirk RW, Bonagura J, eds: Current Veterinary Therapy XII. Philadelphia, WB Saunders, 1994, p 749. Review of specific and symptomatic treatment modalities for chronic hepatitis in the dog.
Rutgers HC, Hay wood S, Kelly DF: Idiopathic hepatic fibrosis in 15 dogs. VetRec 133:115, 1993. Retrospective study describing clinical signs and follow-up in 15 young dogs with idiopathic hepatic fibrosis.
Van den Ingh TSGAM, Rothuizen J: Lobular dissecting hepatitis in juvenile and young adult dogs. J Vet Intern Med 8:217, 1994. Lobular dissecting hepatitis can cause portal hypertension in young dogs of many breeds.
Van den Ingh TSGAM, Rothuizen J, Meyer HP: Portal hypertension associated with primary hypoplasia of the hepatic portal vein in dogs. Vet Rec 137:424, 1995. Gross or microscopic portal vein hypoplasia as a cause of portal hypertension in young dogs with or without hepatoportal fibrosis.
